SB 2586 In Committee
Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
May 26, 2026 · House
Comp. became Pub. Ch. 1016
Apr 17, 2026 · House
Sponsor(s) Added.
Apr 16, 2026 · House
Companion House Bill substituted
Apr 15, 2026 · House
Sponsor(s) Added.
Apr 15, 2026 · House
Placed on Senate Regular Calendar for 4/16/2026
Apr 15, 2026 · House
Senate Reset on calendar for 4/16/2026
Apr 13, 2026 · House
Placed on Senate Regular Calendar for 4/15/2026
Apr 1, 2026 · Senate
Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
Mar 25, 2026 · House
Placed on Senate Health and Welfare Committee calendar for 4/1/2026
Mar 18, 2026 · House
Reset on Final calendar of Senate Health and Welfare Committee
Mar 17, 2026 · House
Placed on Senate Health and Welfare Committee calendar for 3/18/2026
Mar 17, 2026 · House
Action deferred in Senate Health and Welfare Committee to 3/18/2026
Mar 11, 2026 · House
Placed on Senate Health and Welfare Committee calendar for 3/17/2026
Feb 5, 2026 · Senate
Passed on Second Consideration, refer to Senate Health and Welfare Committee
Feb 2, 2026 · House
Introduced, Passed on First Consideration
Feb 2, 2026 · House
Filed for introduction